Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

Detailed price information for Coya Therapeutics Inc (COYA-Q) from The Globe and Mail including charting and trades.

ide prodrug platform to develop novel product candidates to treat ssRNA viruses, which are a prevalent cause of serious viral diseases. Atea plans to continue to build its pipeline of antiviral ...

Measles is caused by a ssRNA virus belonging to the Paramyxoviridae family, genus Morbillivirus. It has an incubation period of approximately 10–12 days, and clinical disease begins with ...

BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea” or “Company”), a clinical-stage biopharmaceutical company engaged ...

Labroots is excited to host the 7th Annual Event in the Bioprocessing Virtual Event Series on April 2nd, 2025! Bioprocessing, at its core, is the art and science of transforming raw materials into ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Immune memory plays a critical role in the ...